306 related articles for article (PubMed ID: 29175980)
21. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
[TBL] [Abstract][Full Text] [Related]
22. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
23. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
Singhal T; Narayanan TK; Jacobs MP; Bal C; Mantil JC
J Nucl Med; 2012 Nov; 53(11):1709-15. PubMed ID: 23055534
[TBL] [Abstract][Full Text] [Related]
24. Performance of
Li Y; Li F; Han S; Ning J; Su P; Liu J; Qu L; Huang S; Wang S; Li X; Li X
Phenomics; 2023 Dec; 3(6):576-585. PubMed ID: 38223686
[TBL] [Abstract][Full Text] [Related]
25. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
[TBL] [Abstract][Full Text] [Related]
27. Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Kebir S; Khurshid Z; Gaertner FC; Essler M; Hattingen E; Fimmers R; Scheffler B; Herrlinger U; Bundschuh RA; Glas M
Oncotarget; 2017 Jan; 8(5):8294-8304. PubMed ID: 28030820
[TBL] [Abstract][Full Text] [Related]
28. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
29. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography with injection of methionine as a prognostic factor in glioma.
De Witte O; Goldberg I; Wikler D; Rorive S; Damhaut P; Monclus M; Salmon I; Brotchi J; Goldman S
J Neurosurg; 2001 Nov; 95(5):746-50. PubMed ID: 11702862
[TBL] [Abstract][Full Text] [Related]
31. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332
[TBL] [Abstract][Full Text] [Related]
32. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
33. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
34. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
35. Multimodal Imaging of Patients With Gliomas Confirms
Laukamp KR; Lindemann F; Weckesser M; Hesselmann V; Ligges S; Wölfer J; Jeibmann A; Zinnhardt B; Viel T; Schäfers M; Paulus W; Stummer W; Schober O; Jacobs AH
Mol Imaging; 2017 Jan; 16():1536012116687651. PubMed ID: 28654379
[TBL] [Abstract][Full Text] [Related]
36. An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
Takahashi M; Soma T; Mukasa A; Koyama K; Arai T; Momose T
Ann Nucl Med; 2017 Apr; 31(3):250-259. PubMed ID: 28194701
[TBL] [Abstract][Full Text] [Related]
37. Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features.
Zhang X; Yan LF; Hu YC; Li G; Yang Y; Han Y; Sun YZ; Liu ZC; Tian Q; Han ZY; Liu LD; Hu BQ; Qiu ZY; Wang W; Cui GB
Oncotarget; 2017 Jul; 8(29):47816-47830. PubMed ID: 28599282
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
Zhao F; Cui Y; Li M; Fu Z; Chen Z; Kong L; Yang G; Yu J
Nucl Med Biol; 2014 Sep; 41(8):710-5. PubMed ID: 24929963
[TBL] [Abstract][Full Text] [Related]
39. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
[TBL] [Abstract][Full Text] [Related]
40. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]